Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Melincoff Gwen A
http://archive.fast-edgar.com/20260717/AMBO722C8Z22U9ZA22ZN2ZZZ43QCZ2T2Z28G
Filed on: July 17, 2026
Form 8-K Sadot Group Inc. For: Jul 14
http://archive.fast-edgar.com/20260717/A722KQ2CX222HZR2222G2ZE2MTBOO2229282
Filed on: July 17, 2026
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Riley Jeffrey Scott
http://archive.fast-edgar.com/20260717/AMBEV22C8Z22N9ZA22ZE2ZZZSPEGZ2T2Z28G
Filed on: July 17, 2026
Form 6-K QTREX Quantum Ltd. For: Jul 17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of July 2026 (Report No. 3)
Commission File Number: 001-40303
Qtrex Quantum Ltd.
(Translation of registrant’s name into English)
2 Ha-Tidhar St.
Ra’anana 4366504, Israel
(Address of principal executive office)
Indicate by... (continue reading...)
Form 8-K Columbia Financial, Inc. For: Jul 16
July 16, 2026false000211511900021151192026-06-232026-06-23UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 16, 2026 Columbia Financial, Inc. (Exact Name of Registrant as Specified in its Charter) Maryland333-29410342-1991301(State or other jurisdiction(Commission(IRS Employerof incorporation)File... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Canton Strategic Holding For: Jul 13
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: HASLER HANS PETER
-
Form 4 NGL Energy Partners LP For: Jul 15 Filed by: Coady Shawn W
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 4 JABIL INC For: Jul 15 Filed by: Schick Gary K.
-
Form 497 COLUMBIA ACORN TRUST
-
Form 6-K Guardian Metal Resources For: Jul 17
-
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
-
Form 425 ENDRA Life Sciences Inc. Filed by: ENDRA Life Sciences Inc.
-
Form 8-K CROSS COUNTRY HEALTHCARE For: Jul 16
-
Form 8-K Kimbell Royalty Partners For: Jul 16
-
Form F-1/A Genneia S.A.
-
Form D Arrhen, Inc.
-
Form D Goodword Jan 2026 a Seri
-
Form D ANTR-6, a series of ALEX
-
Form D/A ITE Air Fund L.P.
-
Form 8-K INFINITY NATURAL RESOURC For: Jul 17
-
Form D/A Cogniate US Pre-Seed
-
Form 424B3 BANK OF NOVA SCOTIA
-
Form 3 JOHN WILEY & SONS, INC. For: Jul 09 Filed by: Scognamiglio Frank
-
Form 6-K Elevra Lithium Ltd For: Jul 17
-
Form 8-K Polaryx Therapeutics, For: Jul 16
-
Form 8-K Cocrystal Pharma, Inc. For: Jul 14
-
Form D/A BP 2026 AUTO a Series
-
Form D PARKWAY BANCORP INC/IL
-
Form 4 James Hardie Industries For: Jul 15 Filed by: Hill David Lawrence
-
Form 10-Q CLOUDASTRUCTURE, INC. For: Mar 31
-
Form D Shift Capital Apr 2026
-
Form D/A Sachem Head Offshore
-
Form D SSVPM26 a Series of CGF2
-
Form 4 MOGU Inc. For: Jul 13 Filed by: Chen Qi
-
Form D/A Sachem Head LP
-
Form D WITHAI2026 a Series of
-
Form D Kinetic Systems Apr 2026
-
Form D CFI26 a Series of CGF202
-
Form 13F-HR Arbejdsmarkedets Tillaeg For: Jun 30
-
Form 485BXT MEMBERS Life Insurance
-
Form 485BXT AIM COUNSELOR SERIES
-
Form 6-K ECARX Holdings Inc. For: Jul 17
-
Form D Peptomist Partex AI a
-
Form D Fortress Intellectual
-
Form 8-K FNB CORP/PA/ For: Jul 16
-
Form D Fortress Intellectual
-
Form D IGX 2 15 a Series of
-
Form 485BXT MEMBERS Life Insurance
-
Form 6-K Evaxion A/S For: Jul 17
-
Form 8-K SOUTH PLAINS FINANCIAL, For: Jul 16
-
Form 13F-HR Avanza Fonder AB For: Jun 30
-
Form D FF ACC8 Fund a Series
